Messing Up with the Regulator: A Rational AI-driven Drug Design Strategy to Disrupt MiRNA-target Interactions
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Sanchez-Nino M, Ortiz A
. HCV infection and miravirsen. N Engl J Med. 2013; 369(9):877-8.
DOI: 10.1056/NEJMc1307787.
View
2.
Disney M, Winkelsas A, Pradeep Velagapudi S, Southern M, Fallahi M, Childs-Disney J
. Inforna 2.0: A Platform for the Sequence-Based Design of Small Molecules Targeting Structured RNAs. ACS Chem Biol. 2016; 11(6):1720-8.
PMC: 4912454.
DOI: 10.1021/acschembio.6b00001.
View
3.
Tong Y, Lee Y, Liu X, Childs-Disney J, Suresh B, Benhamou R
. Programming inactive RNA-binding small molecules into bioactive degraders. Nature. 2023; 618(7963):169-179.
PMC: 10232370.
DOI: 10.1038/s41586-023-06091-8.
View
4.
Diener C, Keller A, Meese E
. Emerging concepts of miRNA therapeutics: from cells to clinic. Trends Genet. 2022; 38(6):613-626.
DOI: 10.1016/j.tig.2022.02.006.
View
5.
Leitao A, Enguita F
. A Structural View of miRNA Biogenesis and Function. Noncoding RNA. 2022; 8(1).
PMC: 8874510.
DOI: 10.3390/ncrna8010010.
View